6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
23m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
56m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
56m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
56m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
56m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Kezar Life Sciences Inc (NASDAQ:KZR) — investor relations, events, news, and company updates on 6ix.

Latest News

Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences

Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis

Kezar Life Sciences Reports Third Quarter 2025 Financial Results

Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025

Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis and Plans to Explore Strategic Alternatives

Financials

Revenue

$0

Market Cap

$54.55 M

EPS

-7.66

Community Chat

Ask AI